Related Experiment Video
Updated: Oct 31, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
The paracaspase MALT1 in psoriasis.
Stephan Hailfinger1, Klaus Schulze-Osthoff2,3,4
1Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Domagkstr. 3, D-48149 Münster, Germany.
Psoriasis involves immune cells and genetic factors like CARD14 mutations. The paracaspase MALT1 activates key pathways, driving disease progression through its protease and scaffold functions, offering therapeutic targets.
Area of Science:
- Immunodermatology
- Molecular biology
- Genetics
Background:
- Psoriasis is a common autoimmune skin disease involving T cells, keratinocytes, and dendritic cells.
- Genetic variations, including CARD14 mutations, are implicated in psoriasis development.
- Immune and cytokine receptor stimulation activates paracaspase MALT1.
Purpose of the Study:
- To review the role of MALT1-mediated signaling in psoriasis.
- To discuss the therapeutic implications of targeting MALT1 in psoriasis treatment.
Main Methods:
- Review of scientific literature on MALT1 signaling in psoriasis.
- Analysis of the molecular mechanisms of MALT1 in disease pathogenesis.
Main Results:
- MALT1 activation by CARD14 mutations and receptor stimulation.
- MALT1's dual role in psoriasis pathogenesis via protease and scaffold functions.
- MALT1 signaling influences transcription factors NF-κB and AP-1.
Conclusions:
- MALT1 plays a significant role in promoting psoriasis.
- Targeting MALT1-mediated signaling presents potential therapeutic strategies for psoriasis.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway

